NIH-funded research R21 grant

Understanding how corneal cells maintain fluid balance and transparency

Official title: Modeling and testing functional interactions among corneal endothelial acid-base transporters

Funded at State University of New York at Buffalo · NIH-11075886 · Data updated 2026-11-12

This study is looking at how certain proteins in the eye's cornea work together to keep it healthy and clear, and it aims to find out how changes in these proteins might cause corneal dystrophy, which could help in developing new treatments for this condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionState University of New York at Buffalo
NIH-funded
Lab location1 site (Amherst, United States)
Project startMay 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$193,769
NIH project number5R21EY036218-02
Project IDNIH-11075886 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with corneal dystrophies or those experiencing corneal edema.

Less likely to help

Patients with corneal conditions unrelated to the function of the studied transport proteins may not benefit from this research.

What this research studies

This research investigates the interactions between specific proteins in corneal endothelial cells that are crucial for maintaining corneal hydration and transparency. By using a combination of experimental data and computational modeling, the study aims to understand how mutations in these proteins can lead to corneal dystrophy. The researchers will analyze how these proteins work together to counteract pH changes and maintain proper function. This approach could reveal important insights into the mechanisms behind corneal diseases and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for corneal dystrophies, potentially improving vision and quality of life for affected patients.

How similar studies have gone: While the specific approach of using computational modeling in this context may be novel, similar studies have successfully identified interactions among cellular transporters in other conditions.

Where this research is happening

  • State University of New York at Buffalo
    Amherst, United States
    Active

Researchers

  • Principal investigator: Parker, Mark — State University of New York at Buffalo
  • Study coordinator: Parker, Mark

Related research

Other NIH-funded projects on the same topics.

  • Improving population health by studying reproductive health and development.

    This study is looking at how different factors, like the environment and genetics, affect the health of pregnant women and people of reproductive age, with the goal of improving pregnancy outcomes and the health of children as they grow up.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-9795452

  • How noise and hearing loss affect the first step of hearing in the brain

    This NIH grant studies how noise and conductive hearing loss change the intimate connections between auditory nerves and brain cells, which could influence how we hear in noisy environments.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11620270

  • Programmable hydrogels to protect transplanted human OPCs in demyelinating disease

    Aims to improve survival and integration of transplanted human oligodendrocyte precursor cells by using specially designed hydrogels to reduce cell death during delivery in demyelinating diseases like multiple sclerosis.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11579956

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

  • New dual-acting treatments against tough Klebsiella pneumoniae infections

    A new funding opportunity aims to develop therapies that both fight and disarm the dangerous Klebsiella pneumoniae bacteria, especially strains that resist many drugs, to help patients with serious infections.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11563773

  • Muscle health and aging in postmenopausal women

    This NIH grant supports a study in older, postmenopausal women to understand how insulin and blood sugar relate to muscle loss over time and whether this differs by race/ethnicity.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11532334

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.